The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View

Multiple sclerosis (MS) is a chronic central nervous system inflammatory disease that leads to demyelination and neurodegeneration. The third trimester of pregnancy, which is characterized by high levels of estrogens, has been shown to be associated with reduced relapse rates compared with the rates...

Full description

Bibliographic Details
Main Authors: Alessandro Maglione, Simona Rolla, Stefania Federica De Mercanti, Santina Cutrupi, Marinella Clerico
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/8/10/1280
_version_ 1797713289053995008
author Alessandro Maglione
Simona Rolla
Stefania Federica De Mercanti
Santina Cutrupi
Marinella Clerico
author_facet Alessandro Maglione
Simona Rolla
Stefania Federica De Mercanti
Santina Cutrupi
Marinella Clerico
author_sort Alessandro Maglione
collection DOAJ
description Multiple sclerosis (MS) is a chronic central nervous system inflammatory disease that leads to demyelination and neurodegeneration. The third trimester of pregnancy, which is characterized by high levels of estrogens, has been shown to be associated with reduced relapse rates compared with the rates before pregnancy. These effects could be related to the anti-inflammatory properties of estrogens, which orchestrate the reshuffling of the immune system toward immunotolerance to allow for fetal growth. The action of these hormones is mediated by the transcriptional regulation activity of estrogen receptors (ERs). Estrogen levels and ER expression define a specific balance of immune cell types. In this review, we explore the role of estradiol (E2) and ERs in the adaptive immune system, with a focus on estrogen-mediated cellular, molecular, and epigenetic mechanisms related to immune tolerance and neuroprotection in MS. The epigenome dynamics of immune systems are described as key molecular mechanisms that act on the regulation of immune cell identity. This is a completely unexplored field, suggesting a future path for more extensive research on estrogen-induced coregulatory complexes and molecular circuitry as targets for therapeutics in MS.
first_indexed 2024-03-12T07:34:14Z
format Article
id doaj.art-80faf1f63ddd440d880bb51d4836da12
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-12T07:34:14Z
publishDate 2019-10-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-80faf1f63ddd440d880bb51d4836da122023-09-02T21:35:06ZengMDPI AGCells2073-44092019-10-01810128010.3390/cells8101280cells8101280The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of ViewAlessandro Maglione0Simona Rolla1Stefania Federica De Mercanti2Santina Cutrupi3Marinella Clerico4Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, ItalyDepartment of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, ItalyDepartment of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, ItalyDepartment of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, ItalyDepartment of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, ItalyMultiple sclerosis (MS) is a chronic central nervous system inflammatory disease that leads to demyelination and neurodegeneration. The third trimester of pregnancy, which is characterized by high levels of estrogens, has been shown to be associated with reduced relapse rates compared with the rates before pregnancy. These effects could be related to the anti-inflammatory properties of estrogens, which orchestrate the reshuffling of the immune system toward immunotolerance to allow for fetal growth. The action of these hormones is mediated by the transcriptional regulation activity of estrogen receptors (ERs). Estrogen levels and ER expression define a specific balance of immune cell types. In this review, we explore the role of estradiol (E2) and ERs in the adaptive immune system, with a focus on estrogen-mediated cellular, molecular, and epigenetic mechanisms related to immune tolerance and neuroprotection in MS. The epigenome dynamics of immune systems are described as key molecular mechanisms that act on the regulation of immune cell identity. This is a completely unexplored field, suggesting a future path for more extensive research on estrogen-induced coregulatory complexes and molecular circuitry as targets for therapeutics in MS.https://www.mdpi.com/2073-4409/8/10/1280multiple sclerosisadaptive immune systemepigenomepregnancyestrogensestrogen receptors
spellingShingle Alessandro Maglione
Simona Rolla
Stefania Federica De Mercanti
Santina Cutrupi
Marinella Clerico
The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View
Cells
multiple sclerosis
adaptive immune system
epigenome
pregnancy
estrogens
estrogen receptors
title The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View
title_full The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View
title_fullStr The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View
title_full_unstemmed The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View
title_short The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View
title_sort adaptive immune system in multiple sclerosis an estrogen mediated point of view
topic multiple sclerosis
adaptive immune system
epigenome
pregnancy
estrogens
estrogen receptors
url https://www.mdpi.com/2073-4409/8/10/1280
work_keys_str_mv AT alessandromaglione theadaptiveimmunesysteminmultiplesclerosisanestrogenmediatedpointofview
AT simonarolla theadaptiveimmunesysteminmultiplesclerosisanestrogenmediatedpointofview
AT stefaniafedericademercanti theadaptiveimmunesysteminmultiplesclerosisanestrogenmediatedpointofview
AT santinacutrupi theadaptiveimmunesysteminmultiplesclerosisanestrogenmediatedpointofview
AT marinellaclerico theadaptiveimmunesysteminmultiplesclerosisanestrogenmediatedpointofview
AT alessandromaglione adaptiveimmunesysteminmultiplesclerosisanestrogenmediatedpointofview
AT simonarolla adaptiveimmunesysteminmultiplesclerosisanestrogenmediatedpointofview
AT stefaniafedericademercanti adaptiveimmunesysteminmultiplesclerosisanestrogenmediatedpointofview
AT santinacutrupi adaptiveimmunesysteminmultiplesclerosisanestrogenmediatedpointofview
AT marinellaclerico adaptiveimmunesysteminmultiplesclerosisanestrogenmediatedpointofview